top of page

Representative original research articles (2013 – present): 


Marked reduction of soluble superoxide dismutase-1 (SOD1) in cerebrospinal fluid of patients with recent-onset schizophrenia.  

Coughlin JM, Ishizuka K, Kano SI, Edwards JA, Seifuddin FT, Shimano MA, Daley EL, Zandi PP, Leweke FM, Cascella

 NG, Pomper MG, Yolken RH, Sawa A

Mol Psychiatry. 2013; 18:10-1. 


Inflammatory molecular signature associated with infectious agents in psychosis.  

Hayes LN, Severance EG, Leek JT, Gressitt KL, Rohleder C, CoughlinJM, Leweke FM, Yolken RH, Sawa A 

Schizophr Bull. 2014; 40:963-72. 


Olfactory functioning in first-episode psychosis.  

Kamath V, Lasutschinkow P, Ishizuka K, Sawa A 

Schizophr Bull. 2018; 44:672-680. 


Decoupling of brain temperature and glutamate in recent-onset of schizophrenia: a 7 Tesla 1H-MRS study.  

Posporelis S, Coughlin JM, Marsman A, Pradhan S, Tanaka T, Wang H, Varvaris M, Ward R, Higgs C, Edwards JA, Ford CN, Kim PK, Lloyd AM, Edden RAE, Schretlen DJ, Cascella NG, Barker PB, Sawa A 

Biol Psychiatry Cogn Neurosci Neuroimaging. 2018; 3:248-254. 


Sulforaphane augments glutathione and influences brain metabolites in human subjects: A clinical pilot study.  

Sedlak TW, Nucifora LG, Koga M, Shaffer LS, Higgs C, Tanaka T, Wang AM, Coughlin JM, Barker P, Fahey JW, Sawa A 

Mol Neuropsychiatry. 2018; 3:214-222. 


Contributions of olfactory and neuropsychological assessment to the diagnosis of first-episode schizophrenia. 

Kamath V, Crawford J, DuBois S, Nucifora Jr FC, Nestadt G, Sawa A , Schretlen DJ 

Neuropsychology. 2019; 33:203-211. 


Relationship between neuropsychological behavior and brain white matter in first-episode psychosis.  

Faria AV, Crawford J, Ye C, Hsu J, Kenkare A, Scheretlen D, Sawa A 

Schizophr Res. 2019; 208:49-52. 


Assessing brain metabolism with 7 Tesla proton magnetic resonance spectroscopy in first episode psychosis.  

Wang AM, Pradhan S, Coughlin JM, Trivedi A, DuBois SL, Crawford JL, Sedlak TW, Nucifora Jr FC, Nestadt G,

 Nucifora LG, Schretlen DJ, Sawa A , Barker PB 

JAMA Psychiatry. 2019; 76:314-323. 


High availability of the α7 nicotinic acetylcholine receptor in brains of individuals with mild cognitive impairment:  A pilot study using [18F]ASEM PET  

Coughlin JM, Du Y, Rubin LH, Crawford JL, Schretlen DJ, Sawa A, Pomper MG 

J. Nucl. Med. 2020; 61:423-426. 

Association of missense mutation in FOLH1 with decreased NAAG levels and impaired working memory circuitry and cognition.

Zink CF, Barker PB, Sawa A, Weinberger DR, Wang M, Quillian H, Ulrich WS, Chen Q, Jaffe AE, Kleinman JE, Hyde TM, Prettyman GE, Giegerich M, Carta K, Ginkel M, Bigos, K.

Am. J. Psychiatry. 2020; 12:1129-39.



Representative review articles (2013 – present): 



Owen MJ, Sawa A, Mortensen PB 

Lancet. 2016; 388:86-97. 


Clozapine as a model for antipsychotic development.  

Nucifora FC Jr, Mihaljevic M, Lee BJ, Sawa A 

Neurotherapeutics. 2017; 14:750-761 


Application of olfactory tissue and its neural progenitors to schizophrenia and psychiatric research.  

Lavoie J, Sawa A, Ishizuka K 

Curr Opin Psychiatry. 2017; 30:176-183. 


The olfactory neural epithelium as a tool in neuroscience.  

Lavoie J, Gass. Astorga P, Segal-Gavish H, Wu YC, Chung Y, Cascella NG, Sawa A, Ishizuka K 

Trends Mol Med. 2017; 23:100-103. 


Treatment resistant schizophrenia: clinical, biological, and therapeutic perspectives.  

Nucifora FC Jr, Woznica E, Lee BJ, Cascella N, Sawa A 

Neurobiol Dis. 2019; 131:104257. 


Causal inference on pathophysiological mediators in psychiatry.  

Namkung H, Lee B, Sawa A 

Cold Spring Harb. Symp. Quant. Biol. 2019; 83:17-23. 

bottom of page